Business

PRO: Sales up 6% in Q3, with record product approvals and strong royalty growth

PRO: Sales up 6% in Q3, with record product approvals and strong royalty growth

Promimic AbNovember 21, 20243
PRO: Sales up 6% in Q3, with record product approvals and strong royalty growth

About this update from Promimic Ab

Q3 2024 saw 6% sales growth, a positive EBITDA, and a record ten new products approved, with royalty and license revenues up 37% on a rolling basis. The company targets 100 MSEK sales and >40% EBITDA margin by 2026.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Promimic Ab